Information
-
Trademark
-
98349163
-
Serial Number
98349163
-
Registration Number
7658714
-
International Classifications
-
Filing Date
January 09, 2024
a year ago
-
Registration Date
January 21, 2025
4 days ago
-
Transaction Date
January 21, 2025
4 days ago
-
Status Date
January 21, 2025
4 days ago
-
Published for Opposition Date
December 03, 2024
a month ago
-
Location Date
January 20, 2025
5 days ago
-
Status Code
700
-
Current Location
FILE REPOSITORY (FRANCONIA)
Employee Name
PULVERMACHER, TASHA
-
Attorney Docket Number
120075.0118
Attorney Name
Sara M. Bauer
-
Owners
Mark Drawing Code
5
Mark Identification
W
Case File Statements
- DM0000: The mark consists of the stylized letter "W" in gradient shades of dark blue to light blue and dark purple to pink.
- GS0051: Nucleic acid sequences and chemical reagents for medical purposes; pharmaceutical preparations for the treatment of genetic diseases and disorders; genetic medicines for the treatment of diseases and disorders with known genetic cause, component and disease states resulting from gene expression and genetic sequence; nucleic acid therapeutic agents for the treatment of Huntington's disease, Duchenne muscular dystrophy, and alpha-1 antitrypsin deficiency for medical purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of metabolic, cardiometabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, renal, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric, autoimmune, and immune system related diseases and disorders
- PM0001: WAVE
- CC0000: The color(s) dark blue, light blue, dark purple, and pink is/are claimed as a feature of the mark.
- GS0421: Research and development in the fields of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; scientific research; scientific research in the fields of pharmaceuticals, medicine, and nucleic acid therapeutics; research, development, and testing services in the field of nucleic acid therapeutics for medical and scientific applications; medical research; laboratory research services relating to pharmaceuticals
Case File Event Statements
-
1/9/2024 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
4/28/2024 - 9 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
8/5/2024 - 5 months ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
8/7/2024 - 5 months ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
8/7/2024 - 5 months ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
8/7/2024 - 5 months ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
11/6/2024 - 2 months ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
11/6/2024 - 2 months ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
11/6/2024 - 2 months ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
11/7/2024 - 2 months ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
11/27/2024 - a month ago
11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
12/3/2024 - a month ago
12 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
12/3/2024 - a month ago
13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
1/21/2025 - 4 days ago
14 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
1/21/2025 - 4 days ago
15 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC